HLN.L
HLN.L
GB00BMX86B70
HALEON PLC ORD GBP0.01
Loading chart...

Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc has a collaboration agreement with Microsoft to scale digital, data and AI capabilities across the business and accelerate delivery of its global win as one strategy. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Related stocks

SDZ.SW
SDZ.SW • Switzerland
SANDOZ GROUP N
69.72 CHF
36.35B USD 1Y +40.9%
GALD.SW
GALD.SW • Switzerland
GALDERMA GROUP N
164.95 CHF
46.34B USD 1Y +12.1%
SOBI.ST
SOBI.ST • Sweden
Swedish Orphan Biovitrum AB
428.4 SEK
14.92B USD 1Y +35.3%
IPN.PA
IPN.PA • France
IPSEN
142.7 EUR
13.18B USD 1Y +20.7%
MRK.DE
MRK.DE • Germany
MERCK KGAA I
137.85 EUR
67.16B USD 1Y +13%
KNSA
KNSA • United Kingdom
Kiniksa Pharmaceuticals Interna
79.78 USD
6.14B USD 1Y +105.6%
HIK.L
HIK.L • United Kingdom
HIKMA PHARMACEUTICALS PLC ORD S
1,612 GBp
4.41B USD 1Y -12.5%
ALKS
ALKS • Ireland
Alkermes plc
40.61 USD
6.81B USD 1Y +27.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

6/7 High
5Y Volatility
21.5% p.a.
Max Drawdown (5Y)
-22.7%
Sharpe Ratio (5Y)
0.01
Beta Factor
0.28
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
ende